Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7931534, 7 pages
https://doi.org/10.1155/2017/7931534
Research Article

Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage

1Department of Neurosurgery, Poznan University of Medical Sciences, Poznan, Poland
2Department of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Poznan, Poland
3Department of Anaesthesiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland
4Department of General and Interventional Radiology, Poznan University of Medical Sciences, Poznan, Poland

Correspondence should be addressed to Bartosz Sokół; moc.liamg@lokos.zsotrab

Received 15 February 2017; Revised 4 April 2017; Accepted 4 May 2017; Published 29 May 2017

Academic Editor: Sheng Chen

Copyright © 2017 Bartosz Sokół et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Pickard, G. D. Murray, R. Illingworth et al., “Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial,” The British Medical Journal, vol. 298, pp. 636–642, 1989. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Guglielmi, F. Vinuela, J. Dion, and G. Duckwiler, “Electrothrombosis of saccular aneurysms via endovascular approach. Part 2: Preliminary clinical experience,” Journal of Neurosurgery, vol. 75, no. 1, pp. 8–14, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. de Oliveira Manoel, A. Mansur, G. S. Silva, M. R. Germans, B. N. R. Jaja, E. Kouzmina et al., “Functional Outcome After Poor-Grade Subarachnoid Hemorrhage: A Single-Center Study and Systematic Literature Review,” Neurocritical Care, Springer US, vol. 25, pp. 338–350, 2016. View at Publisher · View at Google Scholar
  4. M. D. King, M. D. Laird, S. S. Ramesh et al., “Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics,” Neurosurgical Focus, vol. 28, no. 1, p. E10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sabri, E. Lass, and R. L. MacDonald, “Early brain injury: A common mechanism in subarachnoid hemorrhage and global cerebral ischemia,” Stroke Research and Treatment, Article ID 394036, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Fujii, J. Yan, W. B. Rolland, Y. Soejima, B. Caner, and J. H. Zhang, “Early brain Injury, an evolving frontier in subarachnoid hemorrhage research,” Translational Stroke Research, vol. 4, no. 4, pp. 432–446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Cahill and J. H. Zhang, “Subarachnoid hemorrhage: Is it time for a new direction?” Stroke, vol. 40, no. 3, pp. S86–S87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Zhang, R. M. Pluta, J. Hansen-Schwartz et al., “Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought,” Neurological Research, vol. 31, no. 2, pp. 151–158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. F. A. Sehba, R. M. Pluta, and J. H. Zhang, “Metamorphosis of subarachnoid hemorrhage research: From delayed vasospasm to early brain injury,” Molecular Neurobiology, vol. 43, no. 1, pp. 27–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Brathwaite and R. L. Macdonald, “Current management of delayed cerebral ischemia: update from results of recent clinical trials,” Translational Stroke Research, vol. 5, no. 2, pp. 207–226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Kusaka, M. Ishikawa, A. Nanda, D. N. Granger, and J. H. Zhang, “Signaling pathways for early brain injury after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow & Metabolism, vol. 24, pp. 916–925, 2004. View at Publisher · View at Google Scholar
  12. B. R. Choi, W. H. Cho, J. Kim et al., “Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease,” Experimental and Molecular Medicine, vol. 46, article e75, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. P. M. R. Lai and R. Du, “Association between S100B levels and long-term outcome after aneurysmal subarachnoid hemorrhage: Systematic review and pooled analysis,” PLoS ONE, vol. 11, no. 3, Article ID e0151853, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Nakahara, R. Tsuruta, T. Kaneko et al., “High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage,” Neurocritical Care, vol. 11, no. 3, pp. 362–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Sokół, A. Woźniak, R. Jankowski et al., “HMGB1 Level in Cerebrospinal Fluid as a Marker of Treatment Outcome in Patients with Acute Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage,” Journal of Stroke and Cerebrovascular Diseases, vol. 24, no. 8, pp. 1897–1904, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. L. J. Sparvero, D. Asafu-Adjei, R. Kang et al., “RAGE (Receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation,” Journal of Translational Medicine, vol. 7, article no. 17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Ramasamy, S. F. Yan, K. Herold, R. Clynes, and A. M. Schmidt, “Receptor for advanced glycation end products. Fundamental roles in the inflammatory response: Winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis,” Annals of the New York Academy of Sciences, vol. 1126, pp. 7–13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Tang, Y. Wang, Y. Li, H. Lin, S. Manzanero, Y. Hsieh et al., “Functional Role of Soluble Receptor for Advanced Glycation End Products in Stroke,” Arteriosclerosis, Thrombosis, and Vascular Biology, pp. 585–595, 2013. View at Publisher · View at Google Scholar
  19. D. Q. Zhang, R. Wang, T. Li et al., “Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barré syndrome,” Scientific Reports Nature Publishing Group, no. 6, Article ID 21890, 2016. View at Publisher · View at Google Scholar
  20. A. Glasnović, H. Cvija, M. Stojić et al., “Decreased level of sRAGE in the cerebrospinal fluid of multiple sclerosis patients at clinical onset,” NeuroImmunoModulation, vol. 21, no. 5, pp. 226–233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. S. Shah, J. Ebberson, L. A. Kestenbaum, R. L. Hodinka, and J. J. Zorc, “Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants,” Journal of Hospital Medicine, vol. 6, no. 1, pp. 22–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Koroknay-Pál, H. Lehto, M. Niemelä, R. Kivisaari, and J. Hernesniemi, “Long-term outcome of 114 children with cerebral aneurysms,” Journal of Neurosurgery: Pediatrics, vol. 9, no. 6, pp. 636–645, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. E. J. Lee and J. H. Park, “Receptor for advanced glycation endproducts (RAGE), its ligands, and soluble rage: potential biomarkers for diagnosis and therapeutic targets for human renal diseases,” Genomics & Informatics, vol. 11, pp. 224–229, 2013. View at Publisher · View at Google Scholar
  24. M. Neeper, A. Schmidt M, J. Brett, S. D. Yan, F. Wang, Y. C. Pan et al., “Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins,” Journal of Biological Chemistry, vol. 267, pp. 14998–5004, 1992. View at Google Scholar
  25. S. C. Tang, Y. C. Wang, Y. I. Li, H. C. Lin, S. Manzanero, Y. H. Hsieh et al., “Functional role of soluble receptor for advanced glycation end products in stroke,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, pp. 585–594, 2013. View at Publisher · View at Google Scholar
  26. Y. K. Chuah, R. Basir, H. Talib, T. H. Tie, and N. Nordin, “Receptor for advanced glycation end products and its involvement in inflammatory diseases,” International Journal of Inflammation, vol. 2013, Article ID 403460, 15 pages, 2013. View at Publisher · View at Google Scholar
  27. L. Zhang, M. Bukulin, E. Kojro et al., “Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases,” Journal of Biological Chemistry, vol. 283, no. 51, pp. 35507–35516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Gopal, E. P. A. Rutten, M. A. Dentener, E. F. M. Wouters, and N. L. Reynaert, “Decreased plasma sRAGE levels in COPD: Influence of oxygen therapy,” European Journal of Clinical Investigation, vol. 42, no. 8, pp. 807–814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Gopal, N. L. Reynaert, J. L. J. M. Scheijen et al., “Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD,” Respiratory Research, vol. 15, no. 1, article no. 24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Li, W. Wu, Q. Sun et al., “Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage,” Brain Research, vol. 1543, pp. 315–323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. H.-Y. Chou, P.-S. Lee, R. G. Konigsberg et al., “Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage,” Stroke, vol. 42, no. 12, pp. 3624–3627, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. R. G. Whitmore, R. A. Grant, P. Leroux, O. El-Falaki, and S. C. Stein, “How large is the typical subarachnoid hemorrhage? A review of current neurosurgical knowledge,” World Neurosurgery, vol. 77, no. 5-6, pp. 686–697, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Santilli, N. Vazzana, L. G. Bucciarelli, and G. Davì, “Soluble forms of RAGE in human diseases: Clinical and therapeutical implications,” Current Medicinal Chemistry, vol. 16, no. 8, pp. 940–952, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Zhou, J. Shi, C. Hang et al., “Potential contribution of nuclear factor-κB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 9, pp. 1583–1592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. W.-C. You, C.-X. Wang, Y.-X. Pan et al., “Activation of Nuclear Factor-κB in the Brain after Experimental Subarachnoid Hemorrhage and Its Potential Role in Delayed Brain Injury,” PLoS ONE, vol. 8, no. 3, Article ID e60290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Sokół, N. Wąsik, R. Jankowski, M. Hołysz, B. Wiȩckowska, and P. Jagodziński, “Soluble toll-like receptors 2 and 4 in cerebrospinal fluid of patients with acute hydrocephalus following aneurysmal subarachnoid haemorrhage,” PLoS ONE, vol. 11, no. 5, Article ID e0156171, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Quade-Lyssy, A. M. Kanarek, M. Baiersdörfer, R. Postina, and E. Kojro, “Statins stimulate the production of a soluble form of the receptor for advanced glycation end products,” Journal of Lipid Research, vol. 54, no. 11, pp. 3052–3061, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Cheng, L. Wei, S. Zhi-Dan, Z. Shi-Guang, and L. Xiang-Zhen, “Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway,” BMC Neuroscience, vol. 10, article no. 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Potey, T. Ouk, O. Petrault et al., “Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia,” British Journal of Pharmacology, vol. 172, no. 21, pp. 5188–5198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. P. J. Kirkpatrick, C. L. Turner, C. Smith, P. J. Hutchinson, and G. D. Murray, “Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial,” The Lancet Neurology, vol. 13, pp. 666–675, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. K. C. Wang, S. C. Tang, J. E. Lee, Y. I. Li, Y. S. Huang, W. S. Yang et al., “Cerebrospinal fluid high mobility group box 1 is associated with neuronal death in subarachnoid hemorrhage,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, pp. 435–443, 2017. View at Publisher · View at Google Scholar
  42. N. Mahajan, A. Bahl, and V. Dhawan, “C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: Inhibitory effects of atorvastatin,” International Journal of Cardiology, vol. 142, no. 3, pp. 273–278, 2010. View at Publisher · View at Google Scholar · View at Scopus